Axl and EGFR Dual-Specific Binding Affibody for Targeted Therapy in Nasopharyngeal Carcinoma

Axl and EGFR Dual-Specific Binding Affibody for Targeted Therapy in Nasopharyngeal Carcinoma

Nasopharyngeal carcinoma (NPC) is a tumor of the head and neck, with a higher incidence in southern China and Southeast Asia. Radiotherapy and chemotherapy are the main treatments; however, metastasis and recurrence remain the main causes of treatment failure. Further, the majority of patients are d...

Full description

Saved in:
Bibliographic Details
Main Authors: Saidu Kamara, He Wen, Yanru Guo, Ying Liu, Lei Liu, Wangqi Du, Jun Chen, Shanli Zhu, Lifang Zhang
Format: Article
Language:English
Published: MDPI AG 2024-11-01
Series:Cells
Subjects:
affibody molecules
nasopharyngeal carcinoma
Axl
EGFR
targeted therapy
Online Access:https://www.mdpi.com/2073-4409/13/22/1823
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.mdpi.com/2073-4409/13/22/1823

Similar Items